People
The company plans to open a new 90,000 square foot facility this summer. It was a facility that VIVEX’s employees helped design in order to make it as efficient as possible.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 12, 2020.
The restructuring is related to the planned divestiture of Intrarosa (prasterone) and Vyleesi (bremelanotide injection) and the impact of the COVID-19 pandemic.
The government has added additional charges of conspiracy, wire fraud, and forfeiture.
A smartphone diagnostic test for COVID-19 being developed by a University of Utah researcher holds the potential for quick, accurate testing without the need for individuals to go to a healthcare facility. A prototype may be ready within two to three months.
Pharma veteran Michael Varney, Genentech’s head of Research and Development, will retire from the company at the end of July after spending 15 years with the company.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 11, 2020.
AMO Pharma, a British biopharmaceutical company, is targeting a pathway most often associated with cancer to treat people with genetic encephalopathy.
One day after Moderna announced its COVID-19 vaccine candidate has moved into Phase II testing, Chief Executive Officer Stéphane Bancel laid out the bad news – if it works, there won’t be enough of the vaccine to be quickly distributed across the globe.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 8, 2020.
PRESS RELEASES
